Compensation to patient [Regulatives / Guidelines]

posted by Pharma_88 – India, 2025-01-22 14:02 (94 d 02:22 ago) – Posting: # 24344
Views: 1,101

Dear All,

For Bioequivalence study conducted on patients, do we need to provide financial compensation to patients for the participation i.e. Housing or blood loss for Pharmacokinetic evaluation? any guideline from DCGI/ICMR or any regulatory body?

Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
24 visitors (0 registered, 24 guests [including 2 identified bots]).
Forum time: 17:24 CEST (Europe/Vienna)

A drug is that substance which, when injected into a rat,
will produce a scientific report.    Anonymous

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5